Octreotide Acetate LAR Injection

Octreotide Acetate LAR Injection
Details:
Product Name: Octreotide Acetate LAR Injection
  • 2 Cas. 83150-76-9
  • 1 Molecular Formula C49H66N10O10S2
  • 3Molecular Weight 1019.24
  • 6 Appearance Colorless liquid
Send Inquiry
Download
Description
Technical Parameters

BrightGene Health is one of the most reliable manufacturers and suppliers of octreotide acetate lar injection in China. We have world-leading production equipment and strong manufacturing capabilities. Please rest assured to wholesale bulk octreotide acetate lar injection in stock here from our factory.

 

Product introduction

 

Indication: Carcinoid syndrome.
Storage: Sealed, protected from light and stored at 2-8℃.
Octreotide is a synthetic version of somatostatin (a somatostatin analogue) and slows down the production of hormones. Octreotide Acetate LAR Injection helps to control the symptoms of carcinoid syndrome and slow down the growth of the cancer.

Structure

 

product-371-279

 

Certificate Display

 

product-1561-480

 

Exhibition Photos

 

product-1562-559

 

Company Profile

 

product-1561-649

 

 

Hot Tags: octreotide acetate lar injection, China octreotide acetate lar injection manufacturers, suppliers, 83150-76-9, long acting release, Minocycline Hydrochloride LAR Injection, Leuprorelin Acetate LAR Injection, Octreotide Acetate LAR Injection, 13614-98-7

Send Inquiry